The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 49
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte LINGNA LI and VALERYI LISHKO
__________
Appeal No. 2003-1020
Application No. 08/859,0511
__________
HEARD: October 9, 2003
__________
Before WINTERS, LORIN and SCHEINER, Administrative Patent Judges.
SCHEINER, Administrative Patent Judge.
DECISION ON APPEAL
This is an appeal under 35 U.S.C. § 134 from the final rejection of claims 116-
127, all of the claims remaining in the application.
Claims 116 and 122 are representative:
116. A method for treating androgenic alopecia in a subject which method
comprises
applying to the skin of said subject, wherein said skin contains hair follicles, a
formulation of liposomes, which liposomes have incorporated therein at least one active
ingredient selected from the group consisting of
(a) an antisense nucleic acid molecule;
(b) an expression system therefor that hybridizes to an androgen receptor gene
so as to inhibit androgen receptor expression; and
(c) an antiandrogen and
wherein said formulation is free of active ingredient not encapsulated in said
liposomes and
1 Application for patent filed May 20, 1997. According to appellants, this
application is a divisional of application serial no. 08/486,520, filed June 7, 1995, now
U.S. Patent 5,753,263, and a continuation-in-part of application serial no. 08/181,471,
filed January 13, 1994, now U.S. Patent 5,641,508.
Page: 1 2 3 4 5 6 7 8 Next
Last modified: November 3, 2007